NCT05519878Recruiting
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
Assessing Efficacy of a Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
Source: ClinicalTrials.gov · Last updated 19 Oct 2026
Brief summary (registry, in English)
This clinical trial evaluates light therapy and occupational therapy in improving cancer related fatigue (CRF) patients with genitourinary cancers. Light therapy is a non-pharmacological and evidence-based intervention for managing fatigue in cancer patients. The use of light therapy can provide a low burden, inexpensive, and easy to disseminate intervention approach that can potentially have a larger impact on CRF. In addition, occupational therapy is a standard, but often underutilized, component of the multi-disciplinary approach to cancer care. Using the combination of light therapy and occupational therapy may be effective in CRF management.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 224 (estimated)
- First submitted
- 22 Aug 2022
- Start date
- 11 Jan 2023
- Primary completion date
- 29 May 2028
- Lead sponsor
- City of Hope Medical Center
- Diseases
- Prostate cancer, Kidney cancer, Bladder cancer
- NCT number
- NCT05519878
What you commit to
- Study type: Interventional
- Planned participants: 224
- From 11 Jan 2023 to the primary completion date, 29 May 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous use of light therapy to alleviate fatigue or depressive symptoms
- Currently recovering from previous eye surgery within the past 6 months that causes eye irritation
Other illness
- Severe sleep disorders (e.g. narcolepsy)
- Eye Diseases which limit the ability of light to be processed (e.g. untreated cataracts, severe glaucoma, macular degeneration, blindness, pupil dilation problems or other retinal disorder)
- Severe psychological impairment (e.g., bipolar disorder or manic episodes)
- Secondary cancer diagnosis within the past 5 years
- Sensitivity to light, epilepsy, or a history of seizures
Other
- Current employment in night shift work
- Plans to travel across meridians during treatment
- Pregnancy
Who the study is looking for
- Aged 18 and over
- Sufficiently fluent in English
- On active treatment receiving systemic therapy (e.g., chemotherapy, immunotherapy, hormonal therapy, etc.) or radiotherapy
- Patients with diagnosis of a genitourinary (GU) cancer (e.g., prostate, kidney, and bladder cancer) who have grade 1 or 2 fatigue based on physician assessment at the time of study entry
- Clinician assessed prognosis of greater than or equal to six months
- Willing and independently able to provide consent
- Receive a pre-screen FACIT-Fatigue score of less than or equal to 30
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| City of Hope Medical Center Coordinator of this site? Confirm its status | Duarte | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.